NO307956B1 - FremgangsmÕte og apparat for transkraniell elektroterapi - Google Patents

FremgangsmÕte og apparat for transkraniell elektroterapi Download PDF

Info

Publication number: NO307956B1
Authority: NO; Norway
Prior art keywords: signal; current; seconds; tcet; breaks
Prior art date: 1989-11-01

Application number

NO921700A

Other languages

English (en)

Norwegian (no)

Other versions

NO921700D0 (no

NO921700L (no

Inventor

Ifor Donald Capel

Ronald William Davey

Original Assignee

Spes Patents Ltd

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1989-11-01

Filing date

1992-04-30

Publication date

2000-06-26

1992-04-30 Application filed by Spes Patents Ltd filed Critical Spes Patents Ltd

1992-04-30 Publication of NO921700D0 publication Critical patent/NO921700D0/no

1992-06-17 Publication of NO921700L publication Critical patent/NO921700L/no

2000-06-26 Publication of NO307956B1 publication Critical patent/NO307956B1/no

Links

238000000034 method Methods 0.000 title abstract description 15
238000001827 electrotherapy Methods 0.000 title description 2
210000000624 ear auricle Anatomy 0.000 claims abstract description 8
210000000056 organ Anatomy 0.000 claims 1
238000011282 treatment Methods 0.000 abstract description 53
210000003491 skin Anatomy 0.000 abstract description 6
230000000149 penetrating effect Effects 0.000 abstract description 4
210000002615 epidermis Anatomy 0.000 abstract description 2
239000004020 conductor Substances 0.000 abstract 2
230000000694 effects Effects 0.000 description 25
241000700159 Rattus Species 0.000 description 22
208000002193 Pain Diseases 0.000 description 21
230000033228 biological regulation Effects 0.000 description 18
230000036407 pain Effects 0.000 description 16
229940079593 drug Drugs 0.000 description 12
239000003814 drug Substances 0.000 description 12
239000000126 substance Substances 0.000 description 9
208000019901 Anxiety disease Diseases 0.000 description 8
NTYJJOPFIAHURM-UHFFFAOYSA-N Histamine Chemical compound NCCC1=CN=CN1 NTYJJOPFIAHURM-UHFFFAOYSA-N 0.000 description 8
230000000638 stimulation Effects 0.000 description 8
230000036506 anxiety Effects 0.000 description 7
238000012762 unpaired Student’s t-test Methods 0.000 description 7
238000001784 detoxification Methods 0.000 description 6
210000003128 head Anatomy 0.000 description 6
230000001473 noxious effect Effects 0.000 description 6
230000008569 process Effects 0.000 description 6
230000007306 turnover Effects 0.000 description 6
LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 5
241001465754 Metazoa Species 0.000 description 5
230000007958 sleep Effects 0.000 description 5
238000012360 testing method Methods 0.000 description 5
208000007271 Substance Withdrawal Syndrome Diseases 0.000 description 4
230000000903 blocking effect Effects 0.000 description 4
238000006243 chemical reaction Methods 0.000 description 4
229960001340 histamine Drugs 0.000 description 4
239000002858 neurotransmitter agent Substances 0.000 description 4
230000009467 reduction Effects 0.000 description 4
230000028327 secretion Effects 0.000 description 4
230000004936 stimulating effect Effects 0.000 description 4
201000009032 substance abuse Diseases 0.000 description 4
SFLSHLFXELFNJZ-QMMMGPOBSA-N (-)-norepinephrine Chemical compound NC[C@H](O)C1=CC=C(O)C(O)=C1 SFLSHLFXELFNJZ-QMMMGPOBSA-N 0.000 description 3
208000000094 Chronic Pain Diseases 0.000 description 3
108010065372 Dynorphins Proteins 0.000 description 3
108010093625 Opioid Peptides Chemical group 0.000 description 3
102000001490 Opioid Peptides Human genes 0.000 description 3
102100024622 Proenkephalin-B Human genes 0.000 description 3
238000000692 Student's t-test Methods 0.000 description 3
230000009471 action Effects 0.000 description 3
230000001154 acute effect Effects 0.000 description 3
239000008280 blood Substances 0.000 description 3
210000004369 blood Anatomy 0.000 description 3
210000004556 brain Anatomy 0.000 description 3
230000001276 controlling effect Effects 0.000 description 3
230000000147 hypnotic effect Effects 0.000 description 3
230000001537 neural effect Effects 0.000 description 3
230000001722 neurochemical effect Effects 0.000 description 3
229960002748 norepinephrine Drugs 0.000 description 3
SFLSHLFXELFNJZ-UHFFFAOYSA-N norepinephrine Natural products NCC(O)C1=CC=C(O)C(O)=C1 SFLSHLFXELFNJZ-UHFFFAOYSA-N 0.000 description 3
239000003399 opiate peptide Chemical group 0.000 description 3
238000012353 t test Methods 0.000 description 3
208000007848 Alcoholism Diseases 0.000 description 2
208000024827 Alzheimer disease Diseases 0.000 description 2
OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 description 2
101800001982 Cholecystokinin Proteins 0.000 description 2
102100025841 Cholecystokinin Human genes 0.000 description 2
OMFXVFTZEKFJBZ-UHFFFAOYSA-N Corticosterone Natural products O=C1CCC2(C)C3C(O)CC(C)(C(CC4)C(=O)CO)C4C3CCC2=C1 OMFXVFTZEKFJBZ-UHFFFAOYSA-N 0.000 description 2
206010012335 Dependence Diseases 0.000 description 2
206010065390 Inflammatory pain Diseases 0.000 description 2
208000018737 Parkinson disease Diseases 0.000 description 2
206010041349 Somnolence Diseases 0.000 description 2
229910000831 Steel Inorganic materials 0.000 description 2
206010001584 alcohol abuse Diseases 0.000 description 2
208000025746 alcohol use disease Diseases 0.000 description 2
230000003444 anaesthetic effect Effects 0.000 description 2
230000000049 anti-anxiety effect Effects 0.000 description 2
230000003502 anti-nociceptive effect Effects 0.000 description 2
239000002249 anxiolytic agent Substances 0.000 description 2
230000036528 appetite Effects 0.000 description 2
235000019789 appetite Nutrition 0.000 description 2
229910052799 carbon Inorganic materials 0.000 description 2
229940107137 cholecystokinin Drugs 0.000 description 2
230000001713 cholinergic effect Effects 0.000 description 2
235000019504 cigarettes Nutrition 0.000 description 2
230000027288 circadian rhythm Effects 0.000 description 2
OMFXVFTZEKFJBZ-HJTSIMOOSA-N corticosterone Chemical compound O=C1CC[C@]2(C)[C@H]3[C@@H](O)C[C@](C)([C@H](CC4)C(=O)CO)[C@@H]4[C@@H]3CCC2=C1 OMFXVFTZEKFJBZ-HJTSIMOOSA-N 0.000 description 2
230000001419 dependent effect Effects 0.000 description 2
238000006073 displacement reaction Methods 0.000 description 2
VYFYYTLLBUKUHU-UHFFFAOYSA-N dopamine Chemical compound NCCC1=CC=C(O)C(O)=C1 VYFYYTLLBUKUHU-UHFFFAOYSA-N 0.000 description 2
230000003291 dopaminomimetic effect Effects 0.000 description 2
210000005069 ears Anatomy 0.000 description 2
PCHJSUWPFVWCPO-UHFFFAOYSA-N gold Chemical compound [Au] PCHJSUWPFVWCPO-UHFFFAOYSA-N 0.000 description 2
239000010931 gold Substances 0.000 description 2
229910052737 gold Inorganic materials 0.000 description 2
230000003054 hormonal effect Effects 0.000 description 2
229940088597 hormone Drugs 0.000 description 2
239000005556 hormone Substances 0.000 description 2
JYGXADMDTFJGBT-VWUMJDOOSA-N hydrocortisone Chemical compound O=C1CC[C@]2(C)[C@H]3[C@@H](O)C[C@](C)([C@@](CC4)(O)C(=O)CO)[C@@H]4[C@@H]3CCC2=C1 JYGXADMDTFJGBT-VWUMJDOOSA-N 0.000 description 2
230000002045 lasting effect Effects 0.000 description 2
BQJCRHHNABKAKU-KBQPJGBKSA-N morphine Chemical compound O([C@H]1[C@H](C=C[C@H]23)O)C4=C5[C@@]12CCN(C)[C@@H]3CC5=CC=C4O BQJCRHHNABKAKU-KBQPJGBKSA-N 0.000 description 2
230000003533 narcotic effect Effects 0.000 description 2
239000000712 neurohormone Substances 0.000 description 2
229940005483 opioid analgesics Drugs 0.000 description 2
230000001105 regulatory effect Effects 0.000 description 2
210000003296 saliva Anatomy 0.000 description 2
IZTQOLKUZKXIRV-YRVFCXMDSA-N sincalide Chemical compound C([C@@H](C(=O)N[C@@H](CCSC)C(=O)NCC(=O)N[C@@H](CC=1C2=CC=CC=C2NC=1)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](CC=1C=CC=CC=1)C(N)=O)NC(=O)[C@@H](N)CC(O)=O)C1=CC=C(OS(O)(=O)=O)C=C1 IZTQOLKUZKXIRV-YRVFCXMDSA-N 0.000 description 2
230000000391 smoking effect Effects 0.000 description 2
239000010959 steel Substances 0.000 description 2
230000001629 suppression Effects 0.000 description 2
210000001519 tissue Anatomy 0.000 description 2
238000002646 transcutaneous electrical nerve stimulation Methods 0.000 description 2
206010000117 Abnormal behaviour Diseases 0.000 description 1
206010002091 Anaesthesia Diseases 0.000 description 1
208000000103 Anorexia Nervosa Diseases 0.000 description 1
208000006820 Arthralgia Diseases 0.000 description 1
206010054089 Depressive symptom Diseases 0.000 description 1
208000003870 Drug Overdose Diseases 0.000 description 1
206010013935 Dysmenorrhoea Diseases 0.000 description 1
208000030814 Eating disease Diseases 0.000 description 1
241001539473 Euphoria Species 0.000 description 1
206010015535 Euphoric mood Diseases 0.000 description 1
208000019454 Feeding and Eating disease Diseases 0.000 description 1
WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 1
GVGLGOZIDCSQPN-PVHGPHFFSA-N Heroin Chemical compound O([C@H]1[C@H](C=C[C@H]23)OC(C)=O)C4=C5[C@@]12CCN(C)[C@@H]3CC5=CC=C4OC(C)=O GVGLGOZIDCSQPN-PVHGPHFFSA-N 0.000 description 1
208000013016 Hypoglycemia Diseases 0.000 description 1
206010021033 Hypomenorrhoea Diseases 0.000 description 1
206010062767 Hypophysitis Diseases 0.000 description 1
206010061218 Inflammation Diseases 0.000 description 1
208000004404 Intractable Pain Diseases 0.000 description 1
208000012902 Nervous system disease Diseases 0.000 description 1
208000025966 Neurological disease Diseases 0.000 description 1
239000004677 Nylon Substances 0.000 description 1
208000026251 Opioid-Related disease Diseases 0.000 description 1
206010033296 Overdoses Diseases 0.000 description 1
102000003946 Prolactin Human genes 0.000 description 1
108010057464 Prolactin Proteins 0.000 description 1
208000034189 Sclerosis Diseases 0.000 description 1
208000013738 Sleep Initiation and Maintenance disease Diseases 0.000 description 1
208000032140 Sleepiness Diseases 0.000 description 1
FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 1
208000027418 Wounds and injury Diseases 0.000 description 1
230000001919 adrenal effect Effects 0.000 description 1
210000004100 adrenal gland Anatomy 0.000 description 1
230000037005 anaesthesia Effects 0.000 description 1
230000036592 analgesia Effects 0.000 description 1
230000000202 analgesic effect Effects 0.000 description 1
239000005557 antagonist Substances 0.000 description 1
239000000427 antigen Substances 0.000 description 1
102000036639 antigens Human genes 0.000 description 1
108091007433 antigens Proteins 0.000 description 1
230000000712 assembly Effects 0.000 description 1
238000000429 assembly Methods 0.000 description 1
230000001363 autoimmune Effects 0.000 description 1
229940125717 barbiturate Drugs 0.000 description 1
230000006399 behavior Effects 0.000 description 1
230000009286 beneficial effect Effects 0.000 description 1
230000008901 benefit Effects 0.000 description 1
238000005266 casting Methods 0.000 description 1
210000003169 central nervous system Anatomy 0.000 description 1
230000001684 chronic effect Effects 0.000 description 1
230000002060 circadian Effects 0.000 description 1
239000003246 corticosteroid Substances 0.000 description 1
238000009223 counseling Methods 0.000 description 1
230000008878 coupling Effects 0.000 description 1
238000010168 coupling process Methods 0.000 description 1
238000005859 coupling reaction Methods 0.000 description 1
230000006378 damage Effects 0.000 description 1
206010061428 decreased appetite Diseases 0.000 description 1
230000008260 defense mechanism Effects 0.000 description 1
230000006866 deterioration Effects 0.000 description 1
229960002069 diamorphine Drugs 0.000 description 1
208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 1
208000035475 disorder Diseases 0.000 description 1
235000014632 disordered eating Nutrition 0.000 description 1
229960003638 dopamine Drugs 0.000 description 1
231100000725 drug overdose Toxicity 0.000 description 1
206010013781 dry mouth Diseases 0.000 description 1
230000005670 electromagnetic radiation Effects 0.000 description 1
206010015037 epilepsy Diseases 0.000 description 1
230000001856 erectile effect Effects 0.000 description 1
230000007717 exclusion Effects 0.000 description 1
239000012634 fragment Substances 0.000 description 1
210000001652 frontal lobe Anatomy 0.000 description 1
239000008103 glucose Substances 0.000 description 1
244000144993 groups of animals Species 0.000 description 1
239000000380 hallucinogen Substances 0.000 description 1
231100000508 hormonal effect Toxicity 0.000 description 1
229960000890 hydrocortisone Drugs 0.000 description 1
230000002218 hypoglycaemic effect Effects 0.000 description 1
210000000987 immune system Anatomy 0.000 description 1
230000001771 impaired effect Effects 0.000 description 1
238000002513 implantation Methods 0.000 description 1
201000001881 impotence Diseases 0.000 description 1
230000006872 improvement Effects 0.000 description 1
230000004054 inflammatory process Effects 0.000 description 1
230000005764 inhibitory process Effects 0.000 description 1
208000014674 injury Diseases 0.000 description 1
206010022437 insomnia Diseases 0.000 description 1
239000007928 intraperitoneal injection Substances 0.000 description 1
230000007794 irritation Effects 0.000 description 1
238000002955 isolation Methods 0.000 description 1
230000003907 kidney function Effects 0.000 description 1
230000003908 liver function Effects 0.000 description 1
238000004519 manufacturing process Methods 0.000 description 1
239000000463 material Substances 0.000 description 1
238000005259 measurement Methods 0.000 description 1
230000007246 mechanism Effects 0.000 description 1
239000002991 molded plastic Substances 0.000 description 1
150000002772 monosaccharides Chemical class 0.000 description 1
229960005181 morphine Drugs 0.000 description 1
238000010137 moulding (plastic) Methods 0.000 description 1
210000003205 muscle Anatomy 0.000 description 1
230000003387 muscular Effects 0.000 description 1
201000006938 muscular dystrophy Diseases 0.000 description 1
230000003880 negative regulation of appetite Effects 0.000 description 1
230000002182 neurohumoral effect Effects 0.000 description 1
210000002569 neuron Anatomy 0.000 description 1
102000008434 neuropeptide hormone activity proteins Human genes 0.000 description 1
108040002669 neuropeptide hormone activity proteins Proteins 0.000 description 1
230000002474 noradrenergic effect Effects 0.000 description 1
229920001778 nylon Polymers 0.000 description 1
229940127240 opiate Drugs 0.000 description 1
201000005040 opiate dependence Diseases 0.000 description 1
230000000945 opiatelike Effects 0.000 description 1
230000027758 ovulation cycle Effects 0.000 description 1
210000001002 parasympathetic nervous system Anatomy 0.000 description 1
230000037361 pathway Effects 0.000 description 1
230000002263 peptidergic effect Effects 0.000 description 1
208000019899 phobic disease Diseases 0.000 description 1
210000003635 pituitary gland Anatomy 0.000 description 1
239000004033 plastic Substances 0.000 description 1
231100000614 poison Toxicity 0.000 description 1
229920001281 polyalkylene Polymers 0.000 description 1
230000007943 positive regulation of appetite Effects 0.000 description 1
238000002360 preparation method Methods 0.000 description 1
229940097325 prolactin Drugs 0.000 description 1
230000002035 prolonged effect Effects 0.000 description 1
238000001671 psychotherapy Methods 0.000 description 1
230000001846 repelling effect Effects 0.000 description 1
230000004044 response Effects 0.000 description 1
201000003068 rheumatic fever Diseases 0.000 description 1
201000000980 schizophrenia Diseases 0.000 description 1
230000000862 serotonergic effect Effects 0.000 description 1
208000012201 sexual and gender identity disease Diseases 0.000 description 1
208000015891 sexual disease Diseases 0.000 description 1
230000004622 sleep time Effects 0.000 description 1
230000037321 sleepiness Effects 0.000 description 1
239000011780 sodium chloride Substances 0.000 description 1
239000000243 solution Substances 0.000 description 1
239000013589 supplement Substances 0.000 description 1
210000002820 sympathetic nervous system Anatomy 0.000 description 1
238000002560 therapeutic procedure Methods 0.000 description 1
239000003440 toxic substance Substances 0.000 description 1
238000011277 treatment modality Methods 0.000 description 1
206010044652 trigeminal neuralgia Diseases 0.000 description 1
XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 1

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
- A61N1/00—Electrotherapy; Circuits therefor
- A61N1/18—Applying electric currents by contact electrodes
- A61N1/32—Applying electric currents by contact electrodes alternating or intermittent currents
- A61N1/36—Applying electric currents by contact electrodes alternating or intermittent currents for stimulation
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
- A61N1/00—Electrotherapy; Circuits therefor
- A61N1/18—Applying electric currents by contact electrodes
- A61N1/32—Applying electric currents by contact electrodes alternating or intermittent currents
- A61N1/36—Applying electric currents by contact electrodes alternating or intermittent currents for stimulation
- A61N1/36014—External stimulators, e.g. with patch electrodes
- A61N1/36021—External stimulators, e.g. with patch electrodes for treatment of pain
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
- A61N1/00—Electrotherapy; Circuits therefor
- A61N1/02—Details
- A61N1/04—Electrodes
- A61N1/05—Electrodes for implantation or insertion into the body, e.g. heart electrode
- A61N1/0502—Skin piercing electrodes
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
- A61N1/00—Electrotherapy; Circuits therefor
- A61N1/18—Applying electric currents by contact electrodes
- A61N1/32—Applying electric currents by contact electrodes alternating or intermittent currents
- A61N1/36—Applying electric currents by contact electrodes alternating or intermittent currents for stimulation
- A61N1/36014—External stimulators, e.g. with patch electrodes
- A61N1/36017—External stimulators, e.g. with patch electrodes with leads or electrodes penetrating the skin
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10S607/00—Surgery: light, thermal, and electrical application
- Y10S607/90—Substance abuse therapy

Landscapes

Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Animal Behavior & Ethology (AREA)
Public Health (AREA)
Biomedical Technology (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Radiology & Medical Imaging (AREA)
Engineering & Computer Science (AREA)
Veterinary Medicine (AREA)
General Health & Medical Sciences (AREA)
Heart & Thoracic Surgery (AREA)
Biophysics (AREA)
Cardiology (AREA)
Pain & Pain Management (AREA)
Electrotherapy Devices (AREA)
Finger-Pressure Massage (AREA)
Nitrogen Condensed Heterocyclic Rings (AREA)
Dental Tools And Instruments Or Auxiliary Dental Instruments (AREA)
Apparatuses And Processes For Manufacturing Resistors (AREA)

NO921700A 1989-11-01 1992-04-30 FremgangsmÕte og apparat for transkraniell elektroterapi NO307956B1 (no)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
GB898924559A GB8924559D0 (en)	1989-11-01	1989-11-01	Method for transcranial electrotherapy
PCT/GB1990/001670 WO1991006340A1 (en)	1989-11-01	1990-10-31	Apparatus and method for transcranial electrotherapy

Publications (3)

Publication Number	Publication Date
NO921700D0 NO921700D0 (no)	1992-04-30
NO921700L NO921700L (no)	1992-06-17
NO307956B1 true NO307956B1 (no)	2000-06-26

Family

ID=10665501

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
NO921700A NO307956B1 (no)	1989-11-01	1992-04-30	FremgangsmÕte og apparat for transkraniell elektroterapi

Country Status (18)

Country	Link
US (1)	US5332401A (ko)
EP (1)	EP0500607B1 (ko)
JP (1)	JP2908019B2 (ko)
KR (1)	KR100186748B1 (ko)
AT (1)	ATE161200T1 (ko)
AU (1)	AU643715B2 (ko)
BR (1)	BR9007805A (ko)
CA (1)	CA2072609C (ko)
DE (2)	DE500607T1 (ko)
DK (1)	DK0500607T3 (ko)
ES (1)	ES2041603T3 (ko)
FI (1)	FI921913A (ko)
GB (2)	GB8924559D0 (ko)
GR (2)	GR930300043T1 (ko)
HU (2)	HU210935B (ko)
NO (1)	NO307956B1 (ko)
RU (1)	RU2113839C1 (ko)
WO (1)	WO1991006340A1 (ko)

Families Citing this family (56)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US6136019A (en) *	1996-08-19	2000-10-24	Mower Family Chf Treatment Irrevocable Trust	Augmentation of electrical conduction and contractility by biphasic cardiac pacing administered via the cardiac blood pool
US6343232B1 (en)	1966-08-19	2002-01-29	Mower Chf Treatment Irrevocable Trust	Augmentation of muscle contractility by biphasic stimulation
US6141587A (en) *	1996-08-19	2000-10-31	Mower Family Chf Treatment Irrevocable Trust	Augmentation of muscle contractility by biphasic stimulation
SE9201453L (sv) *	1992-05-08	1993-07-12	Jens Schouenborg	Medicinsk anordning foer lindring av smaerttillstaand innefattande en elektrodplatta
ZA947493B (en)	1993-09-29	1995-05-29	Tech Pulse Cc	Nerve stimulation apparatus and method
US5697975A (en)	1994-02-09	1997-12-16	The University Of Iowa Research Foundation	Human cerebral cortex neural prosthetic for tinnitus
US7077822B1 (en)	1994-02-09	2006-07-18	The University Of Iowa Research Foundation	Stereotactic hypothalamic obesity probe
US6129685A (en) *	1994-02-09	2000-10-10	The University Of Iowa Research Foundation	Stereotactic hypothalamic obesity probe
US5713922A (en) *	1996-04-25	1998-02-03	Medtronic, Inc.	Techniques for adjusting the locus of excitation of neural tissue in the spinal cord or brain
US6505078B1 (en) *	1996-04-04	2003-01-07	Medtronic, Inc.	Technique for adjusting the locus of excitation of electrically excitable tissue
US5792210A (en) *	1996-06-10	1998-08-11	Environmental Behavior Modification Inc.	Electrical tongue stimulator and method for addiction treatment
GB2314273B (en) *	1996-06-17	2000-09-27	Spes	The use of TCET in the prophylaxis and treatment of allergies
US7440800B2 (en) *	1996-08-19	2008-10-21	Mr3 Medical, Llc	System and method for managing detrimental cardiac remodeling
US6337995B1 (en)	1996-08-19	2002-01-08	Mower Chf Treatment Irrevocable Trust	Atrial sensing and multiple site stimulation as intervention for atrial fibrillation
US6411847B1 (en)	1996-08-19	2002-06-25	Morton M. Mower	Apparatus for applying cyclic pacing at an average rate just above the intrinsic heart rate
US5871506A (en) *	1996-08-19	1999-02-16	Mower; Morton M.	Augmentation of electrical conduction and contractility by biphasic cardiac pacing
US6341235B1 (en)	1996-08-19	2002-01-22	Mower Chf Treatment Irrevocable Trust	Augmentation of electrical conduction and contractility by biphasic cardiac pacing administered via the cardiac blood pool
US7203537B2 (en)	1996-08-19	2007-04-10	Mr3 Medical, Llc	System and method for breaking reentry circuits by cooling cardiac tissue
US6295470B1 (en) *	1996-08-19	2001-09-25	The Mower Family Chf Treatment Irrevocable Trust	Antitachycardial pacing
US7840264B1 (en)	1996-08-19	2010-11-23	Mr3 Medical, Llc	System and method for breaking reentry circuits by cooling cardiac tissue
US7908003B1 (en)	1996-08-19	2011-03-15	Mr3 Medical Llc	System and method for treating ischemia by improving cardiac efficiency
US8447399B2 (en) *	1996-08-19	2013-05-21	Mr3 Medical, Llc	System and method for managing detrimental cardiac remodeling
US6411845B1 (en)	1999-03-04	2002-06-25	Mower Chf Treatment Irrevocable Trust	System for multiple site biphasic stimulation to revert ventricular arrhythmias
US6567702B1 (en) *	1999-10-15	2003-05-20	The Board Of Trustees Of The Leland Stanford Junior University	Eliciting analgesia by transcranial electrical stimulation
US6556869B1 (en)	1999-12-01	2003-04-29	Vertis Neuroscience, Inc.	Electrode introducer for a percutaneous electrical therapy system
US6522927B1 (en)	1999-12-01	2003-02-18	Vertis Neuroscience, Inc.	Electrode assembly for a percutaneous electrical therapy system
US6542780B1 (en)	1999-12-01	2003-04-01	Vertis Neuroscience, Inc.	Method and apparatus for electrically coupling a percutaneous probe
US6549797B1 (en)	1999-12-01	2003-04-15	Vertis Neuroscience, Inc.	Electrode remover for a percutaneous electrical therapy system
US6493592B1 (en) *	1999-12-01	2002-12-10	Vertis Neuroscience, Inc.	Percutaneous electrical therapy system with electrode position maintenance
US6516226B1 (en)	1999-12-01	2003-02-04	Vertis Neuroscience, Inc.	Percutaneous electrical therapy system for minimizing electrode insertion discomfort
US6549810B1 (en)	1999-12-01	2003-04-15	Vertis Neuroscience, Inc.	Percutaneous electrical therapy system with electrode depth control
US6912424B2 (en) *	1999-12-01	2005-06-28	Meagan, Medical, Inc.	Apparatus and method for coupling therapeutic and/or monitoring equipment to a patient
US6622051B1 (en)	1999-12-01	2003-09-16	Vertis Neuroscience, Inc.	Percutaneous electrical therapy system with electrode entry angle control
US6539264B1 (en)	1999-12-01	2003-03-25	Vertis Neuroscience, Inc.	Percutaneous electrical therapy system with sharp point protection
US6560491B1 (en)	1999-12-01	2003-05-06	Vertis Neuroscience, Inc.	Percutaneous electrical therapy system providing electrode axial support
US6904324B2 (en) *	1999-12-01	2005-06-07	Meagan Medical, Inc.	Method and apparatus for deploying a percutaneous probe
BR0006450A (pt) *	1999-12-30	2002-07-23	Circuit Tree Medical Inc	Circuito de controle, dispositivo de corte de tecido e método para acionar um transdutor
US6332096B1 (en)	2000-02-16	2001-12-18	Mower Chf Treatment Irrevocable Trust	Augmentation of electrical conduction and contractility by biphasic cardiac pacing
DE10015026C2 (de)	2000-03-25	2002-05-08	Draeger Medical Ag	Anordnung und Verfahren zur Regelung eines numerischen Werts für die Patientenbeatmung
US6650943B1 (en)	2000-04-07	2003-11-18	Advanced Bionics Corporation	Fully implantable neurostimulator for cavernous nerve stimulation as a therapy for erectile dysfunction and other sexual dysfunction
DE10018518A1 (de) *	2000-04-13	2001-10-25	Walter Paulus	Verfahren und Vorrichtung zur Induktion von Erregbarkeitsänderungen des Gehirns eines Lebewesens
US7118555B2 (en) *	2000-09-21	2006-10-10	Meagan Medical, Inc.	Method and apparatus for repositioning a percutaneous probe
AU2000275456A1 (en)	2000-10-05	2002-04-15	Spes Patents Limited	Apparatus for applying electronic treatment
US6671557B1 (en)	2000-10-10	2003-12-30	Meagan Medical, Inc.	System and method for providing percutaneous electrical therapy
US20050240229A1 (en) *	2001-04-26	2005-10-27	Whitehurst Tood K	Methods and systems for stimulation as a therapy for erectile dysfunction
US6885895B1 (en) *	2001-04-26	2005-04-26	Advanced Bionics Corporation	Methods and systems for electrical and/or drug stimulation as a therapy for erectile dysfunction
WO2004087257A1 (fr) *	2003-04-01	2004-10-14	Qingwei Cheng	Dispositif therapeutique pour le rhume des foins et la rhinite
US7689289B2 (en) *	2006-03-22	2010-03-30	Medtronic, Inc.	Technique for adjusting the locus of excitation of electrically excitable tissue with paired pulses
CA2692512A1 (en) *	2007-07-04	2009-01-08	Hiroshima University	Transcranial electrical stimulation device
US9446234B2 (en)	2007-10-01	2016-09-20	Medtronic, Inc.	Gastric electrical stimulation with lockout interval anti-desensitization feature
US8612008B2 (en) *	2008-10-23	2013-12-17	Electromedical Products International, Inc.	Microcurrent and cranial electrotherapy stimulator for control of anxiety, insomnia, depression and pain
US20100145136A1 (en) *	2008-11-21	2010-06-10	Kirsch Daniel L	Ear clip with pole
US8457765B2 (en)	2008-11-21	2013-06-04	Electromedical Products International, Inc.	Ear clip with pole
KR102249019B1 (ko) *	2013-06-28	2021-05-10	스탑파킨슨 헬스케어 시스템즈 엘엘씨	전기-자극 장치
US10792495B2 (en)	2016-12-01	2020-10-06	Thimble Bioelectronics, Inc.	Neuromodulation device and method for use
RU186964U1 (ru) *	2018-04-17	2019-02-11	Артем Олегович Кузнецов	Устройство безоперационного восстановления опорно-двигательной функции парализованных частей тела и стимуляции поврежденных нервных окончаний

Family Cites Families (17)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US475565A (en) *		1892-05-24		Dumping apparatus
DD22029A (ko) *
US1640061A (en) *	1924-07-02	1927-08-23	Wappler Electric Company Inc	Clamping electrode
GB1467344A (en) *	1974-01-02	1977-03-16	Cardiac Resuscitator Corp	Life sign monitoring apparatus
US3957053A (en) *	1975-03-03	1976-05-18	Yen Kong Woo	Detachably connected acupuncture needles
US4175565A (en) *	1977-06-22	1979-11-27	Oratronics, Inc.	Method and apparatus for stimulating osteogenic activity in bone structure adjacent a dental implant
SU764686A1 (ru) *	1978-06-28	1980-09-23	Центральный Ордена Трудового Красного Знамени Научно-Исследовательский Институт Травматологии И Ортопедии Им. Н.Н.Приорова	Способ стимул ции акупунктурных точек и устройство дл его осуществлени
DE2952818A1 (de) *	1979-12-28	1981-07-02	Biotronik Meß- und Therapiegeräte GmbH & Co Ingenieurbüro Berlin, 1000 Berlin	Elektrode fuer einen implantierbaren herzschrittmacher
US4319584A (en) *	1980-05-19	1982-03-16	Mccall Francis J	Electrical pulse acupressure system
DD204616A1 (de) *	1982-03-04	1983-12-07	Wolfgang Junghans	Klammerelektrode
SU1169653A1 (ru) *	1983-02-04	1985-07-30	Опытно-Конструкторское Бюро "Теплоавтомат"	Устройство дл иглоукалывани
US4646744A (en) *	1984-06-29	1987-03-03	Zion Foundation	Method and treatment with transcranially applied electrical signals
JPS62501192A (ja) *	1984-10-23	1987-05-14	ジオン　フアウンデ−シヨン	電気治療信号供給方法及び装置
US4706679A (en) *	1986-01-27	1987-11-17	Westinghouse Electric Corp.	Disposable monitor for an EEG head set
DE3719353A1 (de) *	1987-06-10	1988-12-22	Sterimed Gmbh	Elektrischer stimulator fuer nerven
FR2627918B1 (fr) *	1988-02-25	1992-10-16	Crepon Francis	Appareil pour generer un signal electrique bidirectionnel asymetrique a polarite predominante
US4982742A (en) *	1989-02-22	1991-01-08	C&Y Technology, Inc.	Apparatus and method to facilitate healing of soft tissue wounds

1989
- 1989-11-01 GB GB898924559A patent/GB8924559D0/en active Pending
1990
- 1990-10-31 KR KR1019920701029A patent/KR100186748B1/ko not_active IP Right Cessation
- 1990-10-31 HU HU9201451A patent/HU210935B/hu not_active IP Right Cessation
- 1990-10-31 HU HU9201451A patent/HU9201451D0/hu unknown
- 1990-10-31 BR BR909007805A patent/BR9007805A/pt not_active IP Right Cessation
- 1990-10-31 RU SU5011786A patent/RU2113839C1/ru not_active IP Right Cessation
- 1990-10-31 CA CA002072609A patent/CA2072609C/en not_active Expired - Fee Related
- 1990-10-31 AU AU66170/90A patent/AU643715B2/en not_active Ceased
- 1990-10-31 US US07/859,478 patent/US5332401A/en not_active Expired - Fee Related
- 1990-10-31 JP JP2514850A patent/JP2908019B2/ja not_active Expired - Lifetime
- 1990-10-31 EP EP90916128A patent/EP0500607B1/en not_active Expired - Lifetime
- 1990-10-31 WO PCT/GB1990/001670 patent/WO1991006340A1/en active IP Right Grant
- 1990-10-31 DK DK90916128T patent/DK0500607T3/da active
- 1990-10-31 ES ES90916128T patent/ES2041603T3/es not_active Expired - Lifetime
- 1990-10-31 DE DE199090916128T patent/DE500607T1/de active Pending
- 1990-10-31 AT AT90916128T patent/ATE161200T1/de not_active IP Right Cessation
- 1990-10-31 DE DE69031838T patent/DE69031838T2/de not_active Expired - Fee Related
1991
- 1991-07-01 GB GB9114200A patent/GB2244654B/en not_active Expired - Fee Related
1992
- 1992-04-29 FI FI921913A patent/FI921913A/fi unknown
- 1992-04-30 NO NO921700A patent/NO307956B1/no not_active IP Right Cessation
1993
- 1993-06-21 GR GR930300043T patent/GR930300043T1/el unknown
1998
- 1998-02-18 GR GR980400338T patent/GR3026163T3/el unknown

Also Published As

Publication number	Publication date
NO921700D0 (no)	1992-04-30
GB2244654A (en)	1991-12-11
BR9007805A (pt)	1992-09-29
CA2072609C (en)	2001-06-19
RU2113839C1 (ru)	1998-06-27
US5332401A (en)	1994-07-26
AU643715B2 (en)	1993-11-25
ES2041603T1 (es)	1993-12-01
GB2244654B (en)	1994-02-09
DE69031838D1 (de)	1998-01-29
ES2041603T3 (es)	1998-04-16
FI921913A0 (fi)	1992-04-29
KR100186748B1 (ko)	1999-05-01
NO921700L (no)	1992-06-17
AU6617090A (en)	1991-05-31
HU9201451D0 (en)	1992-09-28
GB9114200D0 (en)	1991-08-21
HUT61900A (en)	1993-03-29
CA2072609A1 (en)	1991-05-02
DE500607T1 (de)	1993-09-23
JP2908019B2 (ja)	1999-06-21
HU210935B (en)	1995-09-28
GR930300043T1 (en)	1993-06-21
JPH05504492A (ja)	1993-07-15
EP0500607A1 (en)	1992-09-02
KR920703150A (ko)	1992-12-17
GB8924559D0 (en)	1989-12-20
GR3026163T3 (en)	1998-05-29
EP0500607B1 (en)	1997-12-17
FI921913A (fi)	1992-04-29
DK0500607T3 (da)	1998-08-24
DE69031838T2 (de)	1998-07-16
WO1991006340A1 (en)	1991-05-16
ATE161200T1 (de)	1998-01-15

Legal Events

Date	Code	Title	Description
2004-10-11	MM1K	Lapsed by not paying the annual fees

Publication	Publication Date	Title
NO307956B1 (no)	2000-06-26	FremgangsmÕte og apparat for transkraniell elektroterapi
Ulett et al.	1998	Electroacupuncture: mechanisms and clinical application
Berman et al.	2011	Clinical acupuncture: scientific basis
White et al.	2002	Acupuncture for smoking cessation
US4646744A (en)	1987-03-03	Method and treatment with transcranially applied electrical signals
Tsubokawa et al.	1984	Thalamic relay nucleus stimulation for relief of intractable pain. Clinical results and β-endorphin immunoreactivity in the cerebrospinal fluid
McLennan et al.	1977	Some pharmacological observations on the analgesia induced by acupuncture in rabbits
Ernst et al.	1986	Pain perception decrement produced through repeated stimulation
US20080154334A1 (en)	2008-06-26	Method of pain relief in patients after abdominal/pelvic surgery
Gersh et al.	1985	Applications of transcutaneous electrical nerve stimulation in the management of patients with pain: state-of-the-art update
Han	1993	Acupuncture and stimulation produced analgesia
CN110650771A (zh)	2020-01-03	对偏头痛发作进行紧急非侵入性治疗的外部三叉神经刺激
Kroening et al.	1985	Rapid narcotic detoxification in chronic pain patients treated with auricular electroacupuncture and naloxone
Lin et al.	2011	The mechanistic studies of acupuncture and moxibustion in Taiwan
Pomeranz	1989	Acupuncture research related to pain, drug addiction and nerve regeneration
Hsiang-Tung	1974	Integrative action of thalamus in the process of acupuncture for analgesia
Hsieh et al.	2000	Analgesic effect of electric stimulation of peripheral nerves with different electric frequencies using the formalin test
Han et al.	2011	Acupuncture-related techniques for the treatment of opiate addiction: a case of translational medicine
Chang	1974	Integrative action of thalamus in the process of acupuncture for analgesia
Bjørn et al.	1987	Successful treatment of itching and atopic eczema by transcutaneous nerve stimulation
Oleson	2001	Neurophysiological basis of auricular acupuncture
Willer et al.	1986	The enkephalinase inhibitor, GB 52, does not affect nociceptive flexion reflexes nor pain sensation in humans
Lapeer	1986	High-Intensity Transcutaneous Nerve Stimulation at the Hoku Acupuncture Point for Relief of Muscular Headache Pain: Literature Review and Clinical Trial
Patterson et al.	1992	Neuroelectric therapy (NET) in addiction detoxification
Takeshige	2002	Mechanisms of Acupuncture Analgesia Produced by Low-Frequency Electrical Stimulation of Acupuncture Points